Your browser doesn't support javascript.
loading
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens.
Yan, Jun; Nielsen, Travis B; Lu, Peggy; Talyansky, Yuli; Slarve, Matt; Reza, Hernan; Novakovic, Boris; Netea, Mihai G; Keller, Ashley E; Warren, Troy; DiGiandomenico, Antonio; Sellman, Bret R; Luna, Brian M; Spellberg, Brad.
Affiliation
  • Yan J; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Nielsen TB; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Lu P; UC San Diego School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
  • Talyansky Y; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Slarve M; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Reza H; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Novakovic B; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Netea MG; Murdoch Children's Research Institute and Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, VIC 3052, Australia.
  • Keller AE; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
  • Warren T; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.
  • DiGiandomenico A; AstraZeneca Inc., Early Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
  • Sellman BR; AstraZeneca Inc., Early Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
  • Luna BM; AstraZeneca Inc., Early Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
  • Spellberg B; AstraZeneca Inc., Early Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
Sci Transl Med ; 15(716): eadf9556, 2023 10 04.
Article in En | MEDLINE | ID: mdl-37792959
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Cross Infection / Methicillin-Resistant Staphylococcus aureus / Anti-Infective Agents Limits: Animals Language: En Journal: Sci Transl Med Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Cross Infection / Methicillin-Resistant Staphylococcus aureus / Anti-Infective Agents Limits: Animals Language: En Journal: Sci Transl Med Year: 2023 Document type: Article